These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9734388)

  • 1. The art of tolerance.
    Starzl TE
    Nat Med; 1998 Sep; 4(9):1006-8. PubMed ID: 9734388
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection.
    Ehl S; Aichele P; Ramseier H; Barchet W; Hombach J; Pircher H; Hengartner H; Zinkernagel RM
    Nat Med; 1998 Sep; 4(9):1015-9. PubMed ID: 9734393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor cell persistence and activation-induced unresponsiveness of peripheral CD8+ T cells.
    Ehl S; Barchet W; Oehen S; Aichele P; Hombach J; Hengartner H; Zinkernagel RM
    Eur J Immunol; 2000 Mar; 30(3):883-91. PubMed ID: 10741405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
    Bättig P; Saudan P; Storni T; Gallimore A; Bachmann MF
    Microbes Infect; 2005 Apr; 7(4):729-37. PubMed ID: 15857805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology.
    Aichele P; Brduscha-Riem K; Oehen S; Odermatt B; Zinkernagel RM; Hengartner H; Pircher H
    Immunity; 1997 May; 6(5):519-29. PubMed ID: 9175830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralymphatic immunization enhances DNA vaccination.
    Maloy KJ; Erdmann I; Basch V; Sierro S; Kramps TA; Zinkernagel RM; Oehen S; Kündig TM
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3299-303. PubMed ID: 11248073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can we stimulate the immune system in vivo?
    Zinkernagel RM
    Dev Biol Stand; 1992; 77():29-30. PubMed ID: 1426669
    [No Abstract]   [Full Text] [Related]  

  • 8. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.
    Tissot AC; Ciatto C; Mittl PR; Grütter MG; Plückthun A
    J Mol Biol; 2000 Sep; 302(4):873-85. PubMed ID: 10993729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
    DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
    J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity and tolerance of virus-specific T cells.
    Zinkernagel RM; Pircher HP; Schulz M; Leist T; Oehen S; Hengartner H
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():843-51. PubMed ID: 2701218
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides.
    Kyburz D; Aichele P; Speiser DE; Hengartner H; Zinkernagel RM; Pircher H
    Eur J Immunol; 1993 Aug; 23(8):1956-62. PubMed ID: 8344359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo.
    Pircher H; Moskophidis D; Rohrer U; Bürki K; Hengartner H; Zinkernagel RM
    Nature; 1990 Aug; 346(6285):629-33. PubMed ID: 1696684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antigen-presenting cells in mediating tolerance and autoimmunity.
    Garza KM; Chan SM; Suri R; Nguyen LT; Odermatt B; Schoenberger SP; Ohashi PS
    J Exp Med; 2000 Jun; 191(11):2021-7. PubMed ID: 10839816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.
    Hangartner L; Zellweger RM; Giobbi M; Weber J; Eschli B; McCoy KD; Harris N; Recher M; Zinkernagel RM; Hengartner H
    J Exp Med; 2006 Aug; 203(8):2033-42. PubMed ID: 16880253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective activation of CD8 T cell effector functions by epitope variants of lymphocytic choriomeningitis virus glycoprotein.
    Martin S; Kohler H; Weltzien HU; Leipner C
    J Immunol; 1996 Sep; 157(6):2358-65. PubMed ID: 8805633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology. Tolerance by exhaustion.
    von Boehmer H
    Nature; 1993 Apr; 362(6422):696. PubMed ID: 8469279
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.
    Hudrisier D; Riond J; Gairin JE
    J Virol; 2001 Mar; 75(5):2468-71. PubMed ID: 11160751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.